BNET Industries

Market Cap:$140.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer says cuts may help research
-
Status Of Pfizer And Wyeth Research Facilities
-
Monsanto MON Agrees to Acquire Pfizer's PFE Chesterfield Village Research Center for $435M
-
Pfizer slashing 600 jobs from its St. Louis area work force [St. Louis Post-Dispatch]
-
UPDATE: Abbott Labs: US Justice Department Probing Depakote
-
Trubion loses $6.2 million in Q3
-
BRIEF: Pfizer, Ligand ink JAK-3 pact
-
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
-
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment...
-
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 4, 2009 : FLML, XING, AFFY and MOCO
-
Pfizer unveils its new Poultry Health division
-
Pfizer reportedly considers buying Protalix
-
Pfizer, GSK launch HIV drug company
-
Pfizer eyes deal with Israel's Protalix-newspaper
-
Report: Pfizer may make a bid for Protalix
-
Wockhardt says no plans to divest biotech biz
-
Pfizer Is Ordered to Pay $850,000 to Brigham Young U. for Delaying Patent Litigation
-
Pfizer leaders get $2.2 million in bonuses
-
AstraZeneca Settles Seroquel Probe
News & Analysis
Filter by
hartford courant and pfizer inc. - All News and Analysis
Connecticut thinks huge Pfizer work force safe, despite Celebrex woes.
By Paul Marks, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Paul Marks, The Hartford Courant, Conn. Knight Ridder/Tribune Business News
Despite Elite Rating, Huge Sales, Expanded Pfizer Still Faces Challenges.
By Matthew Lubanko, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Matthew Lubanko, The Hartford Courant, Conn. Knight Ridder/Tribune Business News
Pfizer Merger May Crimp Innovation.
By Dan Haar, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Dan Haar, The Hartford Courant, Conn. Knight Ridder/Tribune Business News
Economists Say Connecticut Could Feel Later Effects of Pfizer Merger.
By Stacy Wong, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By Stacy Wong, The Hartford Courant, Conn. Knight Ridder/Tribune Business News
Southeastern Connecticut Pfizer Research Facilities Escape Merger-Related Cuts.
By John M. Moran, The Hartford Courant, Conn. Knight Ridder/Tribune Business News By John M. Moran, The Hartford Courant, Conn. Knight Ridder/Tribune Business News
- 1
Industry Transcripts by Seeking Alpha
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
-
Salix Pharmaceuticals Ltd Q3 2009 Earnings Call Transcript
on Nov 09, 2009about SLXP
-
ACADIA Pharmaceuticals, Inc. Q3 2009 Earnings Conference Call
on Nov 09, 2009about ACAD
-
XOMA Ltd. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about XOMA
-
Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
on Nov 06, 2009about HALO
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
